Standard Chemical & Pharmaceutical Co. Ltd. (TPE: 1720)

Standard Chemical & Pharmaceutical Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	1,466	2,037	2,259	2,564	1,036	1,472
Short-Term Investments	120.33	60.5	44.36	57.84	308.54	84.45
Trading Asset Securities	147	178.29	176.15	134.91	136.56	135.82
Cash & Short-Term Investments	1,733	2,276	2,480	2,757	1,481	1,692
Cash Growth	-21.53%	-8.24%	-10.06%	86.13%	-12.46%	16.66%
Accounts Receivable	1,368	1,263	1,263	1,158	942.84	891.91
Other Receivables	17.46	155.84	216.67	331.82	24.41	24.47
Receivables	1,385	1,419	1,480	1,490	967.25	916.37
Inventory	1,628	1,615	1,386	1,218	893.51	914.63
Prepaid Expenses	138.54	103.09	95.21	86.62	93.16	86.56
Other Current Assets	3.72	5.56	148.27	232.89	166.39	4.29
Total Current Assets	4,889	5,418	5,589	5,784	3,602	3,614
Property, Plant & Equipment	4,292	4,301	3,952	2,955	2,389	2,320
Long-Term Investments	1,427	967.73	844.45	769.34	669.49	619.66
Goodwill	173.91	173.91	173.91	162.24	70.27	70.27
Other Intangible Assets	34.06	40.63	51.08	61.38	18.7	26.32
Long-Term Deferred Tax Assets	138.79	141.31	128.37	141.45	138.59	141.58
Other Long-Term Assets	208.33	146.82	228.68	221.04	161.53	135.84
Total Assets	11,163	11,189	10,968	10,095	7,049	6,928
Accounts Payable	546.41	642.99	686.37	624.35	438.57	421.58
Accrued Expenses	265.23	340.88	290.57	141.95	-	-
Short-Term Debt	294.96	800	1,350	1,358	566	865
Current Portion of Long-Term Debt	59.03	59.03	-	-	-	-
Current Portion of Leases	24.17	24.17	21.21	20.35	17.54	13.35
Current Income Taxes Payable	127.38	235.19	222.04	164.07	99.09	47.93
Current Unearned Revenue	98.97	83.21	84	79.12	135.66	94.03
Other Current Liabilities	269.23	185.41	225.65	328.28	393.76	371.18
Total Current Liabilities	1,685	2,371	2,880	2,716	1,651	1,813
Long-Term Debt	178.7	222.97	182	50	-	-
Long-Term Leases	209.54	221.72	236.7	239.64	201.66	144.11
Long-Term Deferred Tax Liabilities	83.25	84.27	84.67	83.85	61.99	61.99
Other Long-Term Liabilities	8.86	12.3	0.41	0.53	1.37	18.4
Total Liabilities	2,283	3,051	3,533	3,295	2,144	2,282
Common Stock	1,787	1,787	1,787	1,787	1,787	1,787
Additional Paid-In Capital	299.62	223.89	220.48	204.31	203.27	204.51
Retained Earnings	3,485	3,275	2,862	2,461	1,946	1,702
Comprehensive Income & Other	334.65	13.18	-115.94	-110.33	29.31	70.52
Total Common Equity	5,906	5,299	4,753	4,342	3,966	3,764
Minority Interest	2,974	2,838	2,682	2,458	939.9	882.21
Shareholders' Equity	8,880	8,137	7,436	6,800	4,906	4,646
Total Liabilities & Equity	11,163	11,189	10,968	10,095	7,049	6,928
Total Debt	766.4	1,328	1,790	1,668	785.2	1,022
Net Cash (Debt)	966.59	947.65	689.98	1,089	696.09	669.71
Net Cash Growth	47.12%	37.34%	-36.65%	56.47%	3.94%	33.08%
Net Cash Per Share	5.40	5.30	3.86	6.09	3.89	3.74
Filing Date Shares Outstanding	178.7	178.7	178.7	178.7	178.7	178.7
Total Common Shares Outstanding	178.7	178.7	178.7	178.7	178.7	178.7
Working Capital	3,203	3,047	2,710	3,068	1,951	1,801
Book Value Per Share	33.05	29.65	26.60	24.30	22.19	21.06
Tangible Book Value	5,698	5,084	4,528	4,118	3,877	3,668
Tangible Book Value Per Share	31.89	28.45	25.34	23.05	21.70	20.52
Land	770.54	770.54	770.54	496.34	420.37	515.14
Buildings	2,417	2,190	2,055	1,819	1,671	1,571
Machinery	3,927	3,738	3,196	2,738	2,168	2,074
Construction In Progress	164.01	345.85	385.15	171.35	86.34	33.2

Source: S&P Capital IQ. Standard template. Financial Sources.